Adrian Burden
Directeur Général chez Singular ID Pte Ltd.
Profil
Adrian Burden is Chief Executive Officer and Founder of Singular ID Pte Ltd.
and Founder of the OLED Network of Singapore.
Previously, he was Manager of Business Development and Senior Engineering Fellow of IMRE.
Mr. Burden received a Doctorate in Philosophy from the University of Oxford and an MA degree from the University of Cambridge.
Postes actifs de Adrian Burden
| Sociétés | Poste | Début |
|---|---|---|
Singular ID Pte Ltd.
 Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Directeur Général | 01/12/2004 |
Anciens postes connus de Adrian Burden
| Sociétés | Poste | Fin |
|---|---|---|
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Adrian Burden
| University of Cambridge | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Singular ID Pte Ltd.
Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Technology Services |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
